This inventor holds 12 USPTO granted patents. Top assignees: King Fahd University of Petroleum and Minerals, King Saud University. Active years: 2018-2023.
Location History:
- Dhahran, SA (2021)
- Riyadh, SA (2018 - 2023)
Company Filing History:

Years Active: 2018-2023
Title: The Innovative Contributions of Ali Alhoshani
Introduction
Ali Alhoshani is a prominent inventor based in Riyadh, Saudi Arabia. He has made significant contributions to the field of cancer treatment through his innovative research and development of novel compounds. With a total of 12 patents to his name, Alhoshani's work is recognized for its potential impact on medical science.
Latest Patents
Among his latest patents are the "Platinum(II) ammine selenourea complexes and methods of treating cancer" and "Phosphinogold(I) complexes and methods of treating cancer." The platinum(II) complex of formula (I) showcases his innovative approach to cancer therapy. Additionally, the phosphinogold(I) complexes, which are mixed ligand compounds, have been identified as potent anticancer agents. These complexes exhibit significant cytotoxicity against various cancer cells, including lung, cervical, and liver cancer cells. Alhoshani has also described a pharmaceutical composition that incorporates these complexes, along with methods for synthesizing them and treating cancer.
Career Highlights
Throughout his career, Alhoshani has worked at esteemed institutions such as King Fahd University of Petroleum and Minerals and King Saud University. His research has not only advanced scientific knowledge but has also paved the way for new therapeutic options in oncology.
Collaborations
Alhoshani has collaborated with notable colleagues, including Anvarhusein Abdulkadir Isab and Muhammad Altaf. These partnerships have further enriched his research endeavors and contributed to the development of innovative solutions in cancer treatment.
Conclusion
Ali Alhoshani's contributions to the field of cancer treatment through his patents and research are commendable. His innovative work continues to inspire advancements in medical science and offers hope for improved therapeutic strategies against cancer.